Fig. 7
Drug sensitivity analysis between the CFG22low and CFG22high group. (A) The connectivity map (CMap) analysis predicts the priority of drug of high-risk group. High- and low-risk group was identified according to the median of CFG22 score. (B) The CFG22 score of 62 colorectal cancer (CRC) cells. (C) Long-term proliferation assay shows drug susceptibility of clofibrate in different CRC cells. (D-E) Gene set enrichment analysis of biological process (D) and hallmark (E) of fatty acid metabolic process